Cetya Therapeutics

A pioneering leader in histone deacetylase inhibitor research, focusing on largazole analogs.

News

Seed Round Financing
8 May

Seed Round Financing

$220,000 Round includes Canadian firm InSynchrony Ventures Inc Proceeds will advance oncology drug development (more…)
Colorado Institute for Drug, Device, and Diagnostic Development Investment
1 Feb

Colorado Institute for Drug, Device, and Diagnostic Development Investment

Investment from Colorado Institute for Drug, Device and Diagnostic Development will advance oncology drug development (more…)
Issuance of Third Patent on Largazole Analogs
14 Dec

Issuance of Third Patent on Largazole Analogs

Cetya Therapeutics, Inc. announces the issuance of a third patent to Colorado State University Ventures covering its proprietary portfolio of analogs ...

About

Collaborations

Research and Development